You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HR metastatic breast cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Breast Cancer Trial in Dallas (DB-1303, Capecitabine, Paclitaxel)

Not yet recruiting
  • Metastatic Breast Cancer
  • Dallas, Texas
    Texas Oncology - Baylor Charles A. Sammons Cancer Center
Aug 25, 2023

HR+ Metastatic Breast Cancer, Breast Cancer, Breast Cancer Metastatic Trial in Durham (GMI-1359)

Terminated
  • HR+ Metastatic Breast Cancer
  • +2 more
  • Durham, North Carolina
    Duke University Medical Center
Mar 7, 2022

Brain Metastases, HR+ Metastatic Breast Cancer Trial in Tampa (Stereotactic Radiosurgery (SRS), Abemaciclib, Endocrine therapy)

Recruiting
  • Brain Metastases
  • HR+ Metastatic Breast Cancer
  • Stereotactic Radiosurgery (SRS)
  • +2 more
  • Tampa, Florida
    Moffitt Cancer Center
Nov 1, 2022

Metastatic Breast Cancer Trial (SKB264, Eribulin, Capecitabine)

Not yet recruiting
  • Metastatic Breast Cancer
  • (no location specified)
Oct 7, 2023

Ribociclib in Combination With Hormonal Therapy in HR+/HER2-

Not yet recruiting
  • Breast Cancer
  • ribociclib
  • (no location specified)
Oct 10, 2023

Breast Cancer Trial (Disitamab Vedotin+Anlotinib)

Not yet recruiting
  • Breast Cancer
  • Disitamab Vedotin+Anlotinib
  • (no location specified)
Aug 14, 2023

Breast Cancer Trial in Chengdu (Dalpiciclib combined with Letrozole)

Not yet recruiting
  • Breast Cancer
  • Dalpiciclib combined with Letrozole
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Aug 3, 2023

Metastatic Breast Cancer, Unresectable Breast Cancer Trial in Saint Louis (DiviTum® TKa assay, CDK4/6 + Endocrine therapy)

Not yet recruiting
  • Metastatic Breast Cancer
  • Unresectable Breast Cancer
  • DiviTum® TKa assay
  • CDK4/6 + Endocrine therapy
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 27, 2023

Invasive Mammary Carcinoma, Metastatic Breast Cancer Trial in Nashville (Capecitabine, Endocrine-therapy, MammoPrint ® and

Not yet recruiting
  • Invasive Mammary Carcinoma
  • Metastatic Breast Cancer
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Jan 11, 2023

Treatment Patterns of HR+/HER2- Advanced or Metastatic Breast

Completed
  • HR+/HER2- Advanced or Metastatic Breast Cancer
    • Dublin, Ireland
      Novartis Pharmaceuticals
    May 2, 2023

    Advanced HR-positive and HER2-negative Breast Cancer; CDK4/6 Inhibitor Treatment Failed Trial in Hangzhou (dalpiciclib;

    Recruiting
    • Advanced HR-positive and HER2-negative Breast Cancer; CDK4/6 Inhibitor Treatment Failed
    • dalpiciclib; fluvestrant; compound gossypol acetate tablets
    • Hangzhou, Zhejiang, China
      zhejiangCH
    Nov 9, 2023

    Breast Cancer, Metastatic Breast Cancer, Hormone Receptor Positive Breast Carcinoma Trial in Washington, Baltimore, Hackensack

    Active, not recruiting
    • Breast Cancer
    • +2 more
    • Washington, District of Columbia
    • +4 more
    Jan 31, 2023

    Breast Cancer Trial in Shanghai (Dalpiciclib, Fulvestrant, Pertuzumab)

    Active, not recruiting
    • Breast Cancer
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Oct 10, 2022

    Among HR+/HER2- Advanced or Metastatic Breast Cancer in France

    Recruiting
    • Breast Cancer
    • ribociclib + ET
    • La Roche sur Yon Cedex, France
      Novartis Investigative Site
    Jan 16, 2023

    Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Trial in Ocala (Samuraciclib, Fulvestrant)

    Recruiting
    • Metastatic Breast Cancer
    • +2 more
    • Ocala, Florida
      Ocala Oncology Center PL DBA Florida Cancer Affiliates
    Jul 19, 2023

    Breast Cancer Metastatic Cancer Trial in Shanghai (Apatinib, Dalpiciclib, Fulvestrant/AI)

    Recruiting
    • Breast Cancer Metastatic Cancer
    • Shanghai, Shanghai, China
      Breast cancer institute of Fudan University Cancer Hospital
    Feb 26, 2023

    HR+ Metastatic Breast Cancer Patients Previously Treated With

    Recruiting
    • Breast Cancer
    • Beijing, Beijing, China
      The Fifth Medical Center of PLA General Hospital
    Mar 3, 2022

    Breast Cancer Metastatic Cancer Trial in Shanghai (Fluzoparib, Dalpiciclib, Fulvestrant/AI)

    Recruiting
    • Breast Cancer Metastatic Cancer
    • Shanghai, Shanghai, China
      Breast cancer institute of Fudan University Cancer Hospital
    Feb 26, 2023

    Compare Overall Survival in Medicare Metastatic Breast Cancer

    Active, not recruiting
    • Breast Cancer
    • New York, New York
      Pfizer New York
    Oct 11, 2023

    Invasive Breast Cancer, Metastatic Breast Cancer, HR-Positive Breast Cancer Trial in United States (Pembrolizumab, Sacituzumab

    Recruiting
    • Invasive Breast Cancer
    • +3 more
    • Atlanta, Georgia
    • +7 more
    Nov 14, 2022

    Luminal Metastatic breAst caNcer in Real-life Clinical pracTice

    Completed
    • HR+/HER2- Breast Cancer
    • +2 more
    • Moscow, Russian Federation
      Russian Society of Clinical Oncology
    Mar 29, 2023

    Locally Advanced or Unresectable Metastatic Breast Cancer, Stage IV Breast Cancer Trial in Marietta, East Brunswick (Sacituzumab

    Recruiting
    • Locally Advanced or Unresectable Metastatic Breast Cancer
    • Stage IV Breast Cancer
    • Sacituzumab Govitecan-hziy
    • +3 more
    • Marietta, Georgia
    • +1 more
    Apr 21, 2023

    CDK4/6 Inhibitors Combined With Endocrine Therapy and Subsequent

    Not yet recruiting
    • Breast Cancer
    • +3 more
    • Different treatment regimens following progression on CDK4/6 inhibitors.
    • (no location specified)
    Sep 5, 2023

    Breast Cancer Patients Diagnosed With HR+/HER2- Locally Advanced

    Active, not recruiting
    • Breast Cancer
      • Copenhagen, Denmark
        Danish Breast Cancer Group
      Jul 6, 2022

      Learn About Use and Effects of CDK4/6 Inhibitors in Canadian

      Active, not recruiting
      • Breast Cancer
        • Kirkland, Quebec, Canada
          Pfizer Canada
        Mar 5, 2023